Chinese herbal medicine for resistant hypertension: a systematic review.

ABSTRACT:

Objectives

This study aimed to summarise the current evidence from randomised control trials (RCTs) concerning treatment of patients with resistant hypertension with Chinese herbal medicine (CHM).

Design

Seven databases, including the Cochrane Library, PubMed, EMBASE, CNKI, VIP, CBM and Wanfang, were systematically searched from their inception to March 2014 for RCTs investigating treatment of resistant hypertension in which CHM was used either as a monotherapy or in combination with conventional medicine versus placebo, no intervention or conventional medicine.

Results

Five trials containing 446 hypertensive patients were identified. The methodological quality of most trials was evaluated as generally low. All included trials compared CHM plus antihypertensive drugs

SUBMITTER: Xiong X 

PROVIDER: S-EPMC4316421 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature